Atlas Trials

Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)

Clinical trial NCT00240877 · COMPLETED

Trial details

NCT number
NCT00240877
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2002-08-01
Primary completion
2003-08-01
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.